RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Under RAPS

Posted 01 June 2010

Due diligence is the term used to describe the process of evaluating potential business transactions or partnerships to identify and mitigate risk. As healthcare products, including pharmaceuticals and biotechnology-based products, are developed, manufactured and marketed in an increasingly complex and global regulatory environment, various agencies' regulations and intricate regulatory considerations can make or break potential business deals, large and small.

 

© 2022 Regulatory Affairs Professionals Society.